Finance

Lists
Why is WQ5 down 13,89%?
Dive Deeper
WQ5:FRA
Genflow Biosciences PLC
€0,016
-13,89%
(-0,0025) 1D
12 Okt., 08:55:01 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for WQ5...
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
10,97 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,04
52-wk low
€0,01
No. of employees
5
Open
€0,02
High
€0,02
Low
€0,02
Mkt. cap
10,97 m
Avg. vol.
0,00
Volume
0,00
52-wk high
€0,04
52-wk low
€0,01
No. of employees
5
News stories
From web sources and news partners
About Genflow Biosciences PLC
CEO-
Employees5
Founded2020
Headquarters-
Sector-
Previous reportsAll values in GBP
Loading Previous Earnings...
Revenue
Net income
All values in GBP
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
292,80 k
292,80 k
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
555,24 k
555,24 k
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-45,57 k
-45,57 k
227,16 k
227,16 k
Operating expense
632,78 k
632,78 k
209,86 k
209,86 k
Total operating expenses
632,78 k
632,78 k
209,86 k
209,86 k
Operating income
-339,97 k
-339,97 k
-209,86 k
-209,86 k
Other non operating income
-
-
-
-
EBT including unusual items
-339,97 k
-339,97 k
-210,12 k
-210,12 k
EBT excluding unusual items
-339,97 k
-339,97 k
-210,12 k
-210,12 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
122,55 k
122,55 k
-17,29 k
-17,29 k
Net income
-339,97 k
-339,97 k
-210,12 k
-210,12 k
Net profit margin
-116,11%
-116,11%
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-253,00
-253,00
Net interest expenses
-
-
-253,00
-253,00
Depreciation and amortization charges
547,00
547,00
-
-
EBITDA
-339,72 k
-339,72 k
-209,72 k
-209,72 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google-programme